LGR5 Antibodies

Santa Cruz Biotechnology provides a broad selection of LGR5 monoclonal antibodies for research focused on understanding LGR5 protein functions. The monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). LGR5, or Leucine-rich repeat-containing G protein-coupled receptor 5, serves as a critical marker for stem cells in various tissues, particularly in the intestinal epithelium. LGR5 plays a significant role in regulating stem cell proliferation and differentiation, making it essential for maintaining tissue homeostasis and regeneration. Research has shown that LGR5 expression is altered in several cancers, highlighting its importance in both developmental biology and oncology research. Understanding LGR5's role in stem cell biology has opened new avenues for investigating tissue regeneration and cancer development. Ongoing studies continue to reveal new functions and regulatory mechanisms of LGR5 in different biological processes. LGR5 research has significant implications for developing targeted therapies in regenerative medicine and cancer treatment. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of LGR5's role in health and disease.